treatment of non-small-cell lung cancer with erlotinib following gefitinib-induced hepatotoxicity review of 8 clinical cases与埃罗替尼治疗非小细胞肺癌后gefitinib-induced肝毒性的8个临床病例.pdfVIP

  • 4
  • 0
  • 约4.75万字
  • 约 7页
  • 2017-08-29 发布于上海
  • 举报

treatment of non-small-cell lung cancer with erlotinib following gefitinib-induced hepatotoxicity review of 8 clinical cases与埃罗替尼治疗非小细胞肺癌后gefitinib-induced肝毒性的8个临床病例.pdf

treatment of non-small-cell lung cancer with erlotinib following gefitinib-induced hepatotoxicity review of 8 clinical cases与埃罗替尼治疗非小细胞肺癌后gefitinib-induced肝毒性的8个临床病例

Hindawi Publishing Corporation Lung Cancer International Volume 2012, Article ID 354657, 6 pages doi:10.1155/2012/354657 Clinical Study Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases Yukihiro Yano,1 Yoshinobu Namba,1 Masahide Mori,1 Yukie Nakazawa,1 Ayumi Nashi,2 Shinichi Kagami,1 Manabu Niinaka,1 Tsutomu Yoneda,1 Hiromi Kimura,1 Toshihiko Yamaguchi,1 and Soichiro Yokota1 1 Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档